London-based health tech startup Doccla has completed £15 million ($17 million) funding in Series A to operate its patient monitoring service that runs "virtual wards."
The company excels in performing a remote evaluation of the patients' vital signs using sensors. This saves a lot of time for people who usually go to medical centers.
With the combination of AI, electronic health records, and data analytics, the startup is a game-changer in the health industry.
Doccla Virtual Wards
(Photo : National Cancer Institute from Unsplash)
Doccla, the startup behind "Virtual Wards" has completed the $17 million Series A injection anew.
Going to hospitals has become stressful for people since the pandemic started in 2020. Not only is staying at home a practical thing to do, but it's also one good way to avoid contracting COVID-19 outside.
Since this is becoming a problem, especially for individuals who fear getting infected, Doccla came up with the idea that it could effectively assess the patient's conditions even when they're inside their houses.
According to a report by TechCrunch, the startup's venture focuses on remote monitoring of the patients' vital signs on-screen. This means that healthcare specialists are evaluating their state through at-home monitoring.
The so-called virtual ward refers to a type of remote care service that involves taking care of a patient in the home. The tech sector is gradually adopting this trend which helps diminish the cases of overworked clinical staff and other health professionals.
Aside from Doccla, Cera Care Limited and Suvera are known healthcare firms that offer similar virtual services to patients.
Doccla was founded in Sweden in 2019, but it was first launched in the United Kingdom the following year. At the peak of the pandemic era, medical specialists were struggling to manage the patients, especially those who were staying at NHS hospitals.
According to co-founder Martian Ratz, the startup is capable of reducing the usual workload for the NHS thanks to its next-gen technology.
"We look forward to using this new level of support to further build on our success by getting more hospitals on board and developing our technology and clinical capacity in order to help solve the hospital bed crisis and alleviate the immense pressures on the NHS and other healthcare systems," Ratz said in a report by UK Tech.
Related Article: Top 5 HealthTech Startups That Are Experts in Heart Failure
Series A Funding Will Fuel More Development
Expanding the availability and capacity of the clinics is the utmost priority of Doccla. Ratz said that the Series A funding would ignite further developments in the startup, including the addition of AI-powered systems in the health industry.
Ratz envisions that people will experience a "more advanced level of care" in the future. They would also expect the logistical aspect of the firm to improve, as well.
Additionally, Ratz said that they would run virtual clinical trials in the field of pharmaceutical medicine after securing the funding. Regarding the patient's data privacy, Doccla said it would not share personal data with anyone. The company also highlights that it will only collect the data they need to deliver patient care safely and effectively.
Read Also: AI Startups to Follow For Mental Health Care
This article is owned by Tech Times
Written by Joseph Henry
